More recently, Ali and colleagues showed that the prolonged MPO inhibition with PF-1355 in mouse models of MI and ischemia-reperfusion injury (IRI) improved ejection fraction, end-diastolic/systolic volume and left ventricular (LV) hypertrophy. This evidence concerns the gene MPO and myocardial infarction.